Skip to main content
. 2006 Dec;3(12):39–49.

Table 3.

Mean ending doses of SSRIs and SNRIs in the ITT population

SSRI/SNRI plus alprazolam ODT N=125 SSRI/SNRI alone N=120
n Mean Dose (mg/day) n Mean Dose (mg/day)
SSRIs

  • Citalopram

  • Escitalopram

  • Fluoxetine

  • Paroxetine

  • Paroxetine CR

  • Sertraline

  • 2

  • 42

  • 5

  • 7

  • 6

  • 29

  • 15.0

  • 12.5

  • 28.0

  • 23.6

  • 20.4

  • 61.2

  • 2

  • 41

  • 5

  • 8

  • 6

  • 27

  • 30.0

  • 13.8

  • 24.0

  • 21.2

  • 18.8

  • 75.0
SNRIs

  • Duloxetine

  • Venlafaxine

  • Venlafaxine XR

  • 3

  • 4

  • 7

  • 70.0

  • 93.8

  • 112.5

  • 3

  • 10

  • 6

  • 40.0

  • 99.5

  • 112.5
Othera 6 -- 3 --
Not Availableb 14 -- 9 --
a

Subjects not receiving an SSRI/SNRI

b

Subjects for whom an endpoint dose was not recorded, including subjects receiving duloxetine plus alprazolam ODT (n=1), escitalopram plus alprazolam ODT (n=7), paroxetine plus alprazolam ODT (n=1), paroxetine CR plus alprazolam ODT (n=1), sertraline plus alprazolam ODT (n=2), venlafaxine plus alprazolam ODT (n=1), venlafaxine XR plus alprazolam ODT (n=1), escitalopram alone (n=6), fluoxetine alone (n=1), and sertraline alone (n=2)